| 标题 |
Autologous haematopoietic stem-cell transplantation versus bortezomib–melphalan–prednisone, with or without bortezomib–lenalidomide–dexamethasone consolidation therapy, and lenalidomide maintenance for newly diagnosed multiple myeloma (EMN02/HO95): a multicentre, randomised, open-label, phase 3 study |
| 网址 | |
| DOI | |
| 其它 |
期刊:The Lancet Haematology 作者:Michèle Cavo; Francesca Gay; Meral Beksaç; Lucia Pantani; Maria Teresa Petrucci; et al 出版日期:2020-04-30 |
| 求助人 | |
| 下载 | 该求助完结已超 24 小时,文件已从服务器自动删除,无法下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)